The in vitro effect of a calf thymus extract (thymostimulin) on the immunologic parameters of patients with untreated Hodgkin's disease. 1982

M F Martelli, and A Velardi, and P Rambotti, and C Cernetti, and A M Bracaglia, and E Ballatori, and S Davis

The in vitro effect of a calf thymus extract, thymostimulin (TP--1), on the E-rosette-forming capacity and on the PHA blastogenic response of peripheral blood lymphocytes was evaluated in 20 patients with untreated Hodgkin's disease. The mean percentage of lymphocytes forming E rosettes increased in patients from 44.2% to 57.5% (P less than 0.005). The mean PHA stimulation index rose with all three concentrations tested, but returned to the normal range only with the highest PHA concentration (60 mu/ml). An increase in the immune parameters was greatest in those patients who presented with decreased E-rosetting cells of total lymphocyte counts or whose disease was Stage III or IV or of mixed cellular histology.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011336 Probability The study of chance processes or the relative frequency characterizing a chance process. Probabilities
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005260 Female Females
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M F Martelli, and A Velardi, and P Rambotti, and C Cernetti, and A M Bracaglia, and E Ballatori, and S Davis
January 1975, Bollettino dell'Istituto sieroterapico milanese,
M F Martelli, and A Velardi, and P Rambotti, and C Cernetti, and A M Bracaglia, and E Ballatori, and S Davis
January 1976, Przeglad lekarski,
M F Martelli, and A Velardi, and P Rambotti, and C Cernetti, and A M Bracaglia, and E Ballatori, and S Davis
January 1980, The British journal of dermatology,
M F Martelli, and A Velardi, and P Rambotti, and C Cernetti, and A M Bracaglia, and E Ballatori, and S Davis
October 1976, Cancer,
M F Martelli, and A Velardi, and P Rambotti, and C Cernetti, and A M Bracaglia, and E Ballatori, and S Davis
January 1973, Advances in experimental medicine and biology,
M F Martelli, and A Velardi, and P Rambotti, and C Cernetti, and A M Bracaglia, and E Ballatori, and S Davis
May 1979, Clinical and experimental immunology,
M F Martelli, and A Velardi, and P Rambotti, and C Cernetti, and A M Bracaglia, and E Ballatori, and S Davis
January 1977, International archives of allergy and applied immunology,
M F Martelli, and A Velardi, and P Rambotti, and C Cernetti, and A M Bracaglia, and E Ballatori, and S Davis
June 1987, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia,
M F Martelli, and A Velardi, and P Rambotti, and C Cernetti, and A M Bracaglia, and E Ballatori, and S Davis
August 1967, Annals of internal medicine,
M F Martelli, and A Velardi, and P Rambotti, and C Cernetti, and A M Bracaglia, and E Ballatori, and S Davis
July 1999, The Journal of veterinary medical science,
Copied contents to your clipboard!